- Report
- January 2026
- 150 Pages
Global
From €2663EUR$2,963USD£2,312GBP
€3551EUR$3,950USD£3,082GBP
- Report
- July 2025
- 150 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- January 2026
- 191 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- March 2026
- 281 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- March 2026
- 364 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,503GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1798EUR$2,000USD£1,561GBP
- Clinical Trials
- April 2025
- 90 Pages
Global
From €2247EUR$2,500USD£1,951GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1124EUR$1,250USD£975GBP
- Report
- April 2025
- 183 Pages
Global
From €4045EUR$4,500USD£3,511GBP
- Report
- March 2026
- 200 Pages
Global
From €2507EUR$2,789USD£2,176GBP
- Report
- January 2026
- 148 Pages
Global
From €2663EUR$2,963USD£2,312GBP
€3551EUR$3,950USD£3,082GBP
- Report
- October 2025
- 150 Pages
Global
From €4359EUR$4,850USD£3,784GBP
- Report
- August 2025
- 120 Pages
United States
From €3551EUR$3,950USD£3,082GBP
- Report
- November 2018
- 147 Pages
Global
From €2472EUR$2,750USD£2,146GBP
- Report
- December 2024
- 150 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- October 2023
- 145 Pages
Global
From €2831EUR$3,150USD£2,458GBP
- Report
- October 2023
- 145 Pages
Global
From €2831EUR$3,150USD£2,458GBP
- Report
- December 2024
- 84 Pages
Global
From €3551EUR$3,950USD£3,082GBP
- Report
- February 2024
- 168 Pages
Global
From €7146EUR$7,950USD£6,203GBP

Opioid Use Disorder (OUD) is a type of addiction disorder that is characterized by the compulsive use of opioids, such as heroin, morphine, and prescription painkillers. OUD is a serious public health issue, with an estimated 2.1 million people in the United States suffering from the disorder. OUD is associated with a range of physical and psychological health problems, including an increased risk of overdose, infectious diseases, and mental health issues. Treatment for OUD typically involves a combination of medication-assisted treatment (MAT) and psychosocial interventions. MAT involves the use of medications, such as buprenorphine and methadone, to reduce cravings and withdrawal symptoms. Psychosocial interventions include cognitive-behavioral therapy, motivational interviewing, and 12-step programs.
Companies in the OUD market include Indivior, Alkermes, Orexo, and Braeburn Pharmaceuticals. Show Less Read more